ERYTECH Pharma S.A. (ERYP) reports Q3 results

ERYTECH Pharma S.A. (NASDAQ: ERYP) reported Q3 results. Revenue for the quarter came in at $25.77 million versus the consensus estimate of $2.83 million.

For earnings history and earnings-related data on ERYTECH Pharma S.A. (ERYP) click here.

You May Also Be Interested In

• BofA sees Micron EPS topping $230 by FY30, calls peak fears overblown
• UBS: 'We Believe Dollar Tree (DLTR) is Turning From a Transformation to a Growth Story'
• The LGL Group (LGL) Misses Q2 EPS by 8c